-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
ADC Therapeutics SA quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2022 to Q2 2024.
- ADC Therapeutics SA Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$6.67M, a 48.7% increase year-over-year.
- ADC Therapeutics SA Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was -$28M.
- ADC Therapeutics SA annual Nonoperating Income (Expense) for 2023 was -$29.4M, a 25.4% decline from 2022.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)